The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

We obviously, rolled out Zepbound and this is -- we're just now ... that are now going from just weight loss, of course, we lose weight on the drug, the patients lose weight, does it convert ...

The drugmaker launched a campaign supporting its weight loss medication Contrave (Naltrexone/bupropion ... low-cost option or supplemental alternative to the likes of Wegovy and Zepbound. When it ...

There's been growing interest in exploring the broader effects of GLP-1 drugs beyond their use in diabetes and weight loss, too. In December, the FDA approved Zepbound (which has tirzepatide ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

A Lilly-sponsored trial showed last month that Zepbound helped patients lose an average of 20.2% of their weight after 72 weeks, compared to 13.7% for a group treated with Wegovy. In December ...

Even so, this relatively lean state had among the nation’s biggest surges last year in residents taking blockbuster weight-loss drugs ... such as Wegovy and Zepbound in 2024, a 255 percent ...

high-demand drugs now known as "weight-loss" shots: Mounjaro, prescribed for diabetes, and Zepbound, for obesity. If you ask him what he's most excited about, it's not a daily, weekly, or even ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with competitor Eli LIlly’s Zepbound.

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing ...